|
|
||||||||
Department of Environmental Biology, University of Adelaide, Adelaide, South Australia 5005, Australia
| |
ABSTRACT |
|---|
|
|
|---|
Pulmonary surfactant (PS), a mixture of phospholipids and proteins secreted by alveolar type II cells, functions to reduce the surface tension in the lungs of all air-breathing vertebrates. Here we examine the control of PS during lung development in a homeothermic egg-laying vertebrate. In mammals, glucocorticoids and autonomic neurotransmitters contribute to the maturation of the surfactant system. We examined whether dexamethasone, epinephrine, and carbamylcholine hydrochloride (agonist for acetylcholine) increased the amount of PS secreted from cultured type II cells of the developing chicken lung. In particular, we wanted to establish whether dexamethasone would increase PS secretion through a process involving lung fibroblasts. We isolated and cocultured type II cells and lung fibroblasts from chickens after 16, 18, and 20 days of incubation and from hatchlings (day 21). Epinephrine stimulated phosphatidylcholine (PC) secretion at all stages, whereas dexamethasone stimulated secretion of PC at days 16 and 18. Carbamylcholine hydrochloride had no effect at any stage. This is the first study to establish the existence of similar cellular pathways regulating the development of surfactant in chickens and eutherian mammals, despite the vastly different birthing strategies and lung structure and function.
lung development; bird; phosphatidylcholine; type II cell culture; fibroblasts
| |
INTRODUCTION |
|---|
|
|
|---|
THE EVOLUTION OF AIR BREATHING in the vertebrates has occurred independently many times since the Devonian period. Each vertebrate class has members that breathe through lungs, which can vary enormously in structure and complexity (14). Despite the tremendous structural diversity, all vertebrate lungs are internal structures lined with fluid. A high surface tension at the air-liquid interface in the lung would result in a number of ventilatory difficulties, including alveolar collapse and pulmonary edema. Pulmonary surfactant (PS), a mixture of lipids and proteins, functions to reduce surface tension at the air-liquid interface in the lung. PS has been discovered in the lungs of all air-breathing vertebrates examined, including in the parabronchial lung of birds (9).
The morphology and biochemistry of the surfactant system in all vertebrates is highly conserved. Disaturated phospholipids, unsaturated phospholipids, and cholesterol are the dominant lipids in surfactant (10), and phosphatidylcholine (PC) is the most abundant phospholipid class (49). Dipalmitoylphosphatidylcholine is the most abundant phospholipid in mammals and in birds (24, 39). Surfactant lipids and proteins are synthesized in specialized cuboidal alveolar cells, termed type II cells. The components are synthesized in the endoplasmic reticulum and stored in dense, multilayered structures called lamellar bodies (22). Type II cells and lamellar bodies occur in the lungs of reptiles (36, 37, 51), birds (29, 31, 48), and amphibians (16, 18). A surfactant specific protein, SP-A, isolated from mammals, is also present in surfactant isolated from members of each vertebrate group (41, 45). Furthermore, SP-A and SP-B have been detected in epithelial cells of the developing chick lung from the 15th day of incubation (57).
In all vertebrates, the surfactant system is probably most critical at the time when the animal draws its first breath. The removal of lung fluid, a decreased resistance to inflation, and a decrease in pulmonary arteriolar resistance must occur simultaneously with the first breath. The PS system plays a crucial role in the first two of these actions. However, there are many different birthing strategies among the vertebrates. Mammals and birds represent two dramatically different birthing strategies. The transfer from the uterus to air breathing occurs relatively quickly in eutherian mammals. In birds, hatching may take several days, allowing time for lung clearance before pulmonary ventilation. Birds commence breathing by "pipping" into an internal air cell while continuing respiration through the chorioallantoic membrane. Pipping in chickens normally occurs on day 19 of a 21-day incubation period, and pulmonary ventilation commences on day 20 (50).
There are also differences in the developmental processes between birds and mammals. During gestation, mammals are under the influence of maternal hormones. Although the developing chick is under the influence of some hormones in the yolk (30, 40), the transfer of these hormones is likely to differ in terms of the regulation and relative timing throughout incubation. Therefore, these differences in birthing strategy could lead to differences in the mechanisms and timing of control of development of the PS system. However, the surfactant system is crucial to the successful completion of the first breath. Furthermore, it has had only one origin and is highly conserved throughout the radiation of the vertebrates. Therefore, the mechanisms controlling the development of the surfactant system may also be conserved, suggesting that the system as a whole, including its control, has been subject to stabilizing selection.
The control of development of the PS system has never been described in a non-mammalian vertebrate. We know, however, that in chickens, the first lamellar bodies appear in epithelial cells of the parabronchi on day 16 of incubation and then rapidly increase in number (8). The lamellar bodies undergo accelerated differentiation after 18 days of incubation (32). By day 20 of incubation, the lung is fully differentiated to allow for normal breathing, and it contains numerous, large lamellar bodies (33). The total phospholipid content of the lung increases most rapidly after 18 days of incubation (24, 26). The major lung phospholipid throughout the entire incubation period is PC (24), and lamellar bodies isolated from the embryonic chick lung are particularly enriched in PC (32). The proportion of disaturated phospholipids increases significantly toward the end of incubation (26); however, the level of PC as a percentage of total phospholipid remains the same (24). The lung phospholipids in lavage from the adult bird are almost identical in composition to that of mammals (15). Therefore, there are many similarities between the development of the PS system in birds and mammals.
In mammals, maturation of the surfactant system is induced by a complex interaction of factors of both maternal and fetal origin. Glucocorticoids and autonomic neurotransmitters are among the most important factors controlling the development of the surfactant system in mammals. Glucocorticoids have been found to increase surfactant phospholipid synthesis, secretion, and lipid saturation (20) and are believed to mediate their effects on type II cells through interstitial fibroblasts (42). Although there is some evidence to suggest that glucocorticoids contribute to avian surfactant maturation (25, 46, 53), the mechanism remains unclear, in particular whether glucocorticoids will promote secretion of PS from type II cells via a pathway involving fibroblasts.
Adrenergic agonists act directly on mammalian fetal and adult type II
cells (4, 19) through
2-receptors,
stimulating a cAMP-dependent pathway (34). Adrenergic
agonists also promote PS secretion in type II cells isolated from adult
lizards, frogs, and dunnarts (a small heterothermic marsupial)
(54, 55). In eutherian mammals, cholinergic agonists are
believed to act indirectly to stimulate surfactant secretion. These
agents may act on the adrenal glands to release epinephrine and
norepinephrine, which in turn stimulates surfactant release
(38). Alternatively, cholinergic agonists may cause
contraction of smooth muscle cells in the intrapulmonary tissue,
distorting the type II cells and stimulating surfactant secretion
(35). However, acetylcholine elicits surfactant
phospholipid release by acting directly on muscarinic receptors on type
II cells in lizards, dunnarts, frogs, and lungfish (54,
55). It has been proposed that direct cholinergic stimulation
may predominate at low body temperatures in heterothermic animals to
trigger surfactant release without affecting metabolic rate
(55).
Conservation of the pathways controlling development of the surfactant system in two such widely divergent groups of animals as birds and mammals would provide evidence that the surfactant system was crucial to the evolution of air breathing. Furthermore, by comparing two groups of homeotherms, we remove the compounding effects of variations in body temperature. In addition, the development of the chick lung morphology is well described. Therefore, in the present study we examine the effect of dexamethasone, epinephrine, and carbachol on lung cells isolated from the embryonic chicken Gallus gallus.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals. Fertilized chicken eggs (Gallus gallus) were purchased from a commercial supplier (Globe Derby Poultry, Bolivar, South Australia). The eggs were incubated under normoxic conditions at 39°C in a commercially purchased incubator equipped with an automatic turner (Bellsouth, Victoria, Australia). The embryos were sampled after 16, 18 (prepip), and 20 days (postpip) of incubation. Animals were also sampled within 24 h after hatching. Between five and nine individuals were used for each age group, and cells were isolated and cultured from individual animals without pooling cells.
Isolation and coculture of type II cells and fibroblasts. As glucocorticoids are believed to mediate their effects through interstitial fibroblasts, type II cells and fibroblasts were isolated and cocultured. The method used was based on that of Dobbs et al. (12) and Scott et al. (43). The animals were killed with an overdose of pentobarbital sodium (Nembutal; 150 mg/kg body wt, Abbott Laboratories). The lungs were perfused with heparinized PBS solution via the right ventricle until free of blood (2-3 min). The lungs were then excised and minced with scissors in 1 ml of a solution of DNase type I (1 mg/ml, Worthington Biochemicals, Freehold, NJ) in PBS. About 10 ml of a solution of trypsin (0.1%), EDTA (0.02%), and fungicide (10 µg/ml) was added to the minced lung mixture and incubated in a water bath at 37°C for 40 min to dissociate the tissue. The enzyme reaction was stopped by the addition of 10% fetal bovine serum (FBS; Commonwealth Serum Laboratories, Adelaide, Australia). Clumps of tissue were dispersed by trituration and filtered through two layers of gauze followed by filtering through a mesh screen (74 µm pore size). The cell suspension was then centrifuged at 150 g for 8 min, and the resulting cell pellet was gently resuspended in DMEM containing 24 mM NaHCO3 and 10 mM HEPES (Sigma Chemicals). To select type II cells and fibroblasts specifically, 60-mm bacteriologic plastic dishes were coated with a solution of bovine IgG (Sigma Chemicals) and allowed to incubate for 3 h at room temperature. The plates were then washed with 2× PBS and 1× DMEM before the cell suspension was poured onto the plates. The cells were incubated for 1 h 15 min at 37°C in a 10% CO2-90% air incubator. During this time, macrophages and other immune cells bind to the IgG molecules and adhere to the plates, allowing the remainder of the cells (the majority of which are type II cells and fibroblasts) to be poured off. The unattached cells were then centrifuged at 150 g for 8 min, and the pellet was resuspended and incubated in DMEM containing 10% FBS, 10 mM HEPES, 24 mM NaHCO3, 25 U/ml penicillin, 25 µg/ml streptomycin, and 10 µg/ml amphotericin B (Sigma Chemicals). Viability was assessed by exclusion of the vital dye trypan blue, and cell counts were performed using a hemocytometer. Cells were diluted to 2.5 × 106 cells/ml, and 1 µCi/ml [methyl-3H]choline chloride (Amersham) was added to the medium. The cells were then plated at a density of 500,000 cells/cm2 in 96-well tissue culture plates on a layer of human fibronectin (5 µg/cm2, Boehringer Mannheim) and allowed to adhere overnight at 37°C in 10% CO2.
Isolation of type II cells. Type II cells alone were isolated and cultured from seven 18-day embryos to determine if glucocorticoids act through a pathway involving fibroblasts and to confirm that epinephrine acts directly on type II cells. Before the incubation on IgG, the cell suspension was centrifuged at 150 g for 8 min. The cell pellet was resuspended in DMEM containing 10% FBS, poured over 10-cm tissue culture plates, and incubated for 1 h at 37°C in 10% CO2. The cell suspension was removed, and the process was repeated for another 1 h on a fresh plate. During this time, the fibroblasts adhered to the culture dishes, and the remaining cell suspension was centrifuged at 150 g for 8 min. The resulting pellet was resuspended in DMEM (without FBS), applied to the bacteriologic plates coated with IgG, and then isolated and cultured as above.
Agonist stimulation.
After the overnight incubation, the cells were rinsed twice in fresh
DMEM to remove unincorporated choline chloride and unattached cells.
The cells were then incubated in the presence of an agonist dissolved
in DMEM (without FBS) or control in DMEM alone for 4 h. The
control and agonist groups were from the same preparation of cells
(250,000 cells/well in a 96-well tissue culture plate), and each assay
was done in triplicate. The agonists were epinephrine hydrochloride
(100 µM), carbamylcholine hydrochloride (100 µM), and water-soluble
dexamethasone (100 µM) (Sigma Chemicals). To prevent oxidation and
inactivation of the agonists, 1 mM sodium ascorbate (Sigma Chemicals)
was added to all the wells. At day 18, we included
additional experiments to establish if the action of dexamethasone was
mediated through the glucocorticoid receptor and dependent on protein
synthesis. For this, we added 1 µM RU-486 (glucocorticoid receptor
antagonist, Sigma) or 50 µM cycloheximide (protein synthesis
inhibitor, Calbiochem) to wells containing 100 µM dexamethasone. The
media and cell fractions were isolated separately from the wells. A
mixture of chloroform and methanol (1:2) was used to extract lipids
from the media and cellular fractions separately (3).
Unlabeled egg yolk PC (70 µg/ml) (Sigma Chemicals) was added to the
media samples as a carrier to improve the recovery of labeled PC. The
chloroform layer was removed, and the samples were dried under nitrogen
and resuspended in Ready Organic Scintillant (Beckman). The amount of
radioactive PC was measured by liquid scintillation counting (Tricarb
2100TR, Canberra Packard), and the percentage of total PC secreted was
determined by the following equation (44):
|
Cell viability. After the 4-h incubation period, viability of the cells in some wells containing the secretatgogues was assessed by exclusion of the vital dye trypan blue. In addition, a lactate dehydrogenase (LDH) cytotoxicity kit (Roche) was used as a sensitive measure of cell damage. Some test substances interfere with the measurement of LDH by this technique. Therefore, a number of controls were also tested for LDH activity, such as media alone and media containing the agonists. The LDH assay was performed according to the manufacturer's instructions.
Statistical analyses.
Percent changes were arcsin transformed, and the data were
analyzed using one-way analysis of variance followed by paired or
unpaired t-tests. Statistical significance was assumed as
P
0.05.
| |
RESULTS |
|---|
|
|
|---|
Cell purity and viability. Cell yield varied between 2 and 6 million cells/animal, depending on the age of the animal and the degree of lung perfusion. In initial experiments, we found that only ~30% of the cells would attach to the culture dish without the presence of an attachment factor. Plating the cells overnight on a layer of human fibronectin increased the number of attached cells to >85%. After the overnight incubation and rinsing the cells, ~90% of the remaining cells were type II cells and fibroblasts, in a ratio of ~1:1. The few contaminating cell types were macrophages and red blood cells. Thin-layer chromatography indicated that ~90% of radiolabeled choline released into the media was PC. This percentage did not change over the different ages. LDH release was minimal and indicated that the high levels of secretion at day 18 were not due to cell injury. There was no increase in LDH release after the 4-h incubation period in the presence of any of the agonists.
Electron microscopy.
The type II cells isolated from days 16, 18,
20, and hatchling chickens show microvilli, large nuclei,
and lamellar bodies characteristic of type II cells. However, the
number of lamellar bodies in the cells appears to differ between the
various ages. The lamellar bodies at day 16 are small and
few in number (Fig. 1A). At
day 16, there are also a number of large, electron-dense bodies, believed to represent the precursor of lamellar bodies (17, 33). The number of lamellar bodies rapidly increases after 18 days of incubation, with the electron micrograph showing numerous, large lamellar bodies (Fig. 1B), which are
maintained throughout development (Fig. 1, C and
D).
|
Basal PC secretion.
Cocultured type II cells and fibroblasts had the highest level of basal
PC secretion at embryonic day 18. There was a significant increase in basal PC secretion from cocultured cells isolated from
day 16 and day 18 embryos (day 16,
n = 9; day 18, n = 7; P < 0.001, Fig.
2A). At day 18, the
level of basal PC secretion was significantly higher in cocultured type
II cells and fibroblasts than in type II cells alone (n = 7, P = 0.046, Fig. 2B).
|
Agonist stimulation.
Dose-response data for epinephrine and dexamethasone are provided in
Table 1. The increase in PC secretion was
significant with both agonists only at a concentration of 100 µM.
This concentration was used in all other experiments. Epinephrine
stimulated the secretion of PC in cocultured cells isolated after 16 (n = 8, P = 0.034), 18 (n = 7, P = 0.023), and 20 (n = 7, P = 0.037) days of incubation
and also from hatchling chickens (n = 5, P = 0.044, Fig.
3A). Dexamethasone stimulated
PC secretion in cocultured cells isolated from day 16 (n = 7, P = 0.048) and day
18 (n = 7, P = 0.05) embryos (Fig.
4A), but not in day
20 embryos or hatchling chickens. Dexamethasone had no effect on
isolated type II cells in the day 18 chicken
(n = 7, P = 0.313, Fig. 4B),
whereas epinephrine stimulated PC secretion on type II cells alone at
the same time point (n = 7, P = 0.05, Fig. 3B). Dexamethasone had no effect when in the presence
of RU-486 (n = 6, P = 0.327, Table
2) or cycloheximide (n = 6, P = 0.325, Table 1) on cocultured cells at day
18. Carbachol failed to stimulate PC secretion at any embryonic age tested (Table 2).
|
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Validation of methods. This is the first time that embryonic type II cells have been isolated from a non-mammalian species. It is also the first time that non-mammalian type II cells have been cocultured with fibroblasts. Earlier techniques used to isolate type II cells from mammals used differential centrifugation to separate cells on the basis of size and density (28). This technique is not applicable to embryonic type II cells because of the variation in cell size during development, which would result in an enrichment of "mature" type II cells and may not be a true indication of the cell population (7). More recently, elastase and differential adherence on IgG have been used to isolate type II cells (12). Successful isolation of embryonic type II cells has been achieved with the use of IgG adherence (21). However, the enzyme elastase preferentially digests the epithelial layer and hence would not have released fibroblasts from the surrounding tissue.
Our laboratory has previously used collagenase to isolate type II cells from lizard lungs (54). However, to maintain cell viability, a very low concentration was used, which necessarily increased the dissociation time to 12-15 h. This is not appropriate for embryonic type II cells, because they differentiate very rapidly in culture such that they may be no longer representative of the age of the animal from which they were originally isolated (11). Therefore, trypsin was used to release both type II cells and fibroblasts. The use of trypsin as a digestive enzyme has been criticized because it may damage cell membranes and receptors (4). Hence, trypsin was used at a low concentration (0.1%), and exposure to the enzyme was limited to 40 min. This procedure allowed for the rapid dissociation of fibroblasts and type II cells from the surrounding tissue. Minimal LDH release indicated that the cells remained healthy during the isolation and experimental period. Electron microscopy confirmed that the type II cell morphology was identical to that of other species we have previously published (36, 54, 55) as well as to chicken type II cells in situ (31, 32). As shown by both the dexamethasone and epinephrine dose-response data (Table 1), it was necessary to use what is regarded as very high doses (100 µM). Although the concentrations of agonists are well above mammalian physiological levels, cell viability was not affected. This dose of epinephrine has also been previously published and is optimal for use on type II cells isolated from a range of other non-mammalian vertebrates, including lizards, frogs, and lungfish (54, 55) as well as the heterothermic mammal, the fat-tailed dunnart (55). It is possible that non-mammalian cells in general require higher doses to elicit similar responses. It is unclear why this would be the case, but could possibly be related to differences in metabolic rate or receptor number. The time course of 4 h in the presence of the agonists was chosen on the basis of preliminary experiments. It was found that 2 h was often not long enough to elicit a response to dexamethasone, although a response to epinephrine was observed within this period. By 6 h, the response to the agonists had reached a plateau. This is probably due to increased surfactant recycling.Basal PC secretion. Although the levels of PC secretion in vitro are not likely to be the same as those in vivo, we can compare rates between different in vitro preparations isolated from different age animals. In addition, we can relate this to various cellular characteristics in the embryonic chick lung. Levels of basal PC secretion were <1% at day 16. As this is the first day that lamellar bodies are observed in type II cells of embryonic chickens (23, 33), it is not surprising that basal PC secretion is so low. Basal secretion was higher at day 18 than at any other time point. The amount of total phospholipid in tissue (24) and lavage (26) from embryonic chicken lungs is also highest at incubation day 18. This is the day immediately before pulmonary ventilation. Therefore, the higher basal secretion observed in vitro might function to increase surfactant in vivo, which would prepare the animal for air breathing. Fibroblasts appear to have a stimulatory effect on embryonic chicken type II cells in culture at day 18, demonstrated by higher basal PC secretion in coculture. It has been reported that the growth factors produced from lung fibroblasts in the fetal rat are the same at all stages, but their amounts can vary during development (2). During late gestation in the fetal rat, fibroblast populations act to stimulate differentiation of the type II cell phenotype to enable the adequate production of surfactant (5). Therefore, it appears that type II cell-fibroblast interactions are important in the maturation of the surfactant system in birds and in mammals.
Agonist stimulation.
This study demonstrates that epinephrine is a potent stimulator of PC
secretion from embryonic chicken cells. Epinephrine stimulated the
secretion of PC from cells isolated from embryonic chickens of all ages
tested. Adrenergic agonists are also effective in stimulating
surfactant secretion in isolated type II cells from rats immediately
before birth and at 1, 7, 14, and 30 days after parturition
(19). In chickens, the maximal stimulation at day
18 coincides with an increase in plasma epinephrine in the chick
embryo. This increase is induced by hypoxia, which occurs toward the
end of the developmental period (52). The plasma epinephrine may act directly on the type II cells to release PS, which
in turn may prepare the animal for air breathing on day 19.
The adrenergic pathway also appears to be effective posthatch, indicating that this pathway is important in maintaining surfactant secretion beyond the developmental period. Adrenergic agonists also
stimulate surfactant secretion in type II cells isolated from adult
mammalian (4, 6) and non-mammalian vertebrates (54,
55). It is believed that adrenergic agonists bind directly to
-receptors located on the type II cells and activate a
cAMP-dependent signaling pathway to increase surfactant secretion
(4, 6). Our data from day 18 embryos also
indicate that epinephrine acts directly on type II cells in the
chicken. Although this interaction is not dependent on fibroblasts, the
presence of fibroblasts in coculture does enhance the response.
Although the specific adrenergic receptors on type II cells have not
yet been characterized, it is likely that adrenergic agonists act via
the same mechanism.
Perspectives
In mammals, the development of the surfactant system is controlled by many complex and interrelated factors. Two of the most important factors contributing to the maturation of the surfactant system are glucocorticoids and adrenergic agonists. This is the first study to use a coculture system to investigate the control of PS development in a non-mammalian vertebrate. We demonstrated that both glucocorticoids and adrenergic agonists are involved in the development of the PS system in chickens. Furthermore, we showed that adrenergic agonists act directly on type II cells, whereas glucocorticoids require the presence of lung fibroblasts. Therefore, similar control mechanisms are present during lung development in the chicken and in eutherian mammals, despite the vastly different birthing strategies and lung structure and function between the two groups. This provides evidence that all facets of the surfactant system, including its morphology, biochemistry, and regulation, are highly conserved among the vertebrates. Although further research is required to determine the exact nature of the cellular interactions involved in the regulation, our findings may provide the impetus for the use of nontraditional animal models in surfactant research in the future.| |
ACKNOWLEDGEMENTS |
|---|
The authors thank P. Wood, N. Miller, and S. Chamberlain for technical assistance. We thank C. Daniels for critically reviewing the manuscript and S. Johnston for technical help with preparing the manuscript.
| |
FOOTNOTES |
|---|
This research was funded by an Australian Research Council (ARC) grant to C. B. Daniels and an ARC Research Fellowship to S. Orgeig.
Address for reprint requests and other correspondence: S. Orgeig, Dept. of Environmental Biology, Univ. of Adelaide, Adelaide, SA 5005, Australia (E-mail: sandra.orgeig{at}adelaide.edu.au).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 20 April 2000; accepted in final form 1 May 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adamson, IY,
Young L,
and
King GM.
Reciprocal epithelial: fibroblast interactions in the control of fetal and adult rat lung cells in culture.
Exp Lung Res
17:
821-835,
1991[ISI][Medline].
2.
Awonusonu, F,
Srinivasan S,
Strange J,
Al Jumaily W,
and
Bruce MC.
Developmental shift in the relative percentages of lung fibroblast subsets: role of apoptosis postseptation.
Am J Physiol Lung Cell Mol Physiol
277:
L848-L859,
1999
3.
Bligh, EG,
and
Dyer WJ.
A rapid method of total lipid extraction and purification.
Can J Biochem
37:
911-917,
1959[Medline].
4.
Brown, LS,
and
Longmore WJ.
Adrenergic and cholinergic regulation of lung surfactant secretion in the isolated perfused rat lung and in the alveolar type II cell in culture.
J Biol Chem
256:
66-72,
1981
5.
Caniggia, I,
Tseu I,
Han RN,
Smith BT,
Tanswell K,
and
Post M.
Spatial and temporal differences in fibroblast behavior in fetal rat lung.
Am J Physiol Lung Cell Mol Physiol
261:
L424-L433,
1991
6.
Chander, A,
and
Fisher AB.
Regulation of lung surfactant secretion.
Am J Physiol Lung Cell Mol Physiol
258:
L241-L253,
1990
7.
Cockshutt, AM,
and
Possmayer F.
Metabolism of surfactant lipids and proteins in the developing lung.
In: Pulmonary Surfactant: From Molecular Biology to Clinical Practice, edited by Robertson B,
van Golde LMG,
and Batenburg JJ.. Amsterdam: Elsevier Science, 1992, p. 339-377.
8.
Dameron, F,
and
Marin L.
Mode de formation des inclusions lamellaires dans le poumon embryonnaire de poulet.
Z Zellforsch Mikrosk Anat
110:
72-84,
1970[ISI][Medline].
9.
Daniels, CB,
Lopatko OV,
and
Orgeig S.
Evolution of surface activity related functions of vertebrate pulmonary surfactant.
Clin Exp Pharmacol Physiol
25:
716-721,
1998[ISI][Medline].
10.
Daniels, CB,
Orgeig S,
and
Smits AW.
Invited perspective: the evolution of the vertebrate pulmonary surfactant system.
Physiol Zool
68:
539-566,
1995.
11.
Dobbs, LG.
Isolation and culture of alveolar type II cells.
Am J Physiol Lung Cell Mol Physiol
258:
L134-L147,
1990
12.
Dobbs, LG,
Gonzalez R,
and
Williams MC.
An improved method for isolating type II cells in high yield and purity.
Am Rev Respir Dis
134:
141-145,
1986[ISI][Medline].
13.
Dobbs, LG,
and
Mason RJ.
Pulmonary alveolar type II cells isolated from rats.
J Clin Invest
63:
378-387,
1979.
14.
Duncker, HR.
General morphological principles of amniotic lungs.
In: Respiratory Function in Birds, Adult and Embryonic, edited by Piiper J.. Berlin: Springer-Verlag, 1978, p. 2-15.
15.
Fujiwara, T,
Adams FH,
Nozaki M,
and
Dermer GB.
Pulmonary surfactant phospholipids from turkey lung: comparison with rabbit lung.
Am J Physiol
218:
218-225,
1970.
16.
Goniakowska-Witalinska, L.
Lung of the tree frog, Hyla arborea L.
Anat Embryol (Berl)
174:
379-389,
1986[Medline].
17.
Goniakowska-Witalinska, L.
A peculiar mode of formation of the surface lining layer in the lungs of Salamandra salamandra.
Tissue Cell
12:
539-546,
1980[ISI][Medline].
18.
Goniakowska-Witalinska, L.
Tubular myelin structure in the lungs of amphibia. The mode of formation.
Eur J Cell Biol
33:
127-133,
1984[ISI][Medline].
19.
Griese, M,
Gobran LI,
and
Rooney SA.
Ontogeny of surfactant secretion in type II pneumocytes from fetal, newborn, and adult rats.
Am J Physiol Lung Cell Mol Physiol
262:
L337-L343,
1992
20.
Gross, I.
Regulation of fetal lung maturation.
Am J Physiol Lung Cell Mol Physiol
259:
L337-L344,
1990
21.
Gupta, A,
Kaushal S,
Majumdar S,
and
Sanyal SN.
Isolation of type II epithelial cells from rabbit fetal lungs by adherence on an IgG-coated surface.
Experientia
52:
799-802,
1996[ISI][Medline].
22.
Haagsman, HP,
and
Van Golde LMG
Synthesis and assembly of lung surfactant.
Annu Rev Physiol
53:
441-464,
1991[ISI][Medline].
23.
Hylka, VW.
Ultrastructural and biochemical evidence of glycogen in the developing lung of the chick embryo: possible contribution to surfactant.
Comp Biochem Physiol A Physiol
4:
677-683,
1989.
24.
Hylka, VW,
and
Doneen BA.
Lung phospholipids in the embryonic and immature chicken: changes in lipid composition and biosynthesis during maturation of the surfactant system.
J Exp Biol
220:
71-80,
1982.
25.
Hylka, VW,
and
Doneen BA.
Ontogeny of chicken lung: effects of pituitary gland, corticosterone, and other hormones upon pulmonary growth and synthesis of surfactant phospholipids.
Gen Comp Endocrinol
52:
108-120,
1983[ISI][Medline].
26.
Johnston, SD,
Orgeig S,
Lopatko OV,
and
Daniels CB.
Development of the pulmonary surfactant system in two oviparous vertebrates.
Am J Physiol Regulatory Integrative Comp Physiol
278:
R486-R493,
2000
27.
Kalliecharan, R,
and
Hall BK.
A developmental study of the levels of progesterone, corticosterone, cortisol, and cortisone circulating in plasma of chick embryos.
Gen Comp Endocrinol
24:
364-372,
1974[ISI][Medline].
28.
Kikkawa, Y,
and
Yoneda K.
The type II epithelial cell of the lung: I. Method of isolation.
Lab Invest
30:
76-84,
1974[ISI][Medline].
29.
Lambson, RO,
and
Cohn JE.
Ultrastructure of the lung of the goose and its lining of surface material.
J Anat
122:
631-650,
1968.
30.
Lipar, JL,
Ketterson ED,
Nolan VJ,
and
Casto JM.
Egg yolk layers vary in the concentration of steroid hormones in two avian species.
Gen Comp Endocrinol
115:
220-227,
1999[ISI][Medline].
31.
Lopez, CJ,
Sesma CP,
and
Vazquez CJJ
The development of the osmophillic inclusion bodies within the granular pneumocyte of chicken lung.
Anat Rec
210:
597-602,
1984[Medline].
32.
Marin, L,
Dameron F,
Bruner B,
and
Tordet C.
Composition en phospholipides et en acides gras des inclusions lamellaires isolees a partir de poumons de poulets a differents stades du developpement.
C R Acad Sc Paris
289:
1291-1294,
1979.
33.
Marin, L,
Tordet C,
and
Dameron F.
The endocrine control of embryonic lung maturation in the chicken.
Anat Embryol (Berl)
152:
223-234,
1978[Medline].
34.
Mason, RJ,
and
Voelker DR.
Regulatory mechanisms of surfactant secretion.
Biochim Biophys Acta
1408:
226-240,
1998[Medline].
35.
Massaro, D,
Clerch L,
and
Massaro GD.
Surfactant secretion: evidence that cholinergic stimulation of secretion is indirect.
Am J Physiol Cell Physiol
243:
C39-C45,
1982
36.
McGregor, LK,
Daniels CB,
and
Nicholas TE.
Lung ultrastructure and the surfactant-like system of the central netted dragon, Ctenophorus nuchalis.
Copeia
1993:
326-333,
1993.
37.
Nagaishi, C,
Okada Y,
Ishiko S,
and
Daido S.
Electron microscope observations of the pulmonary alveoli.
Exp Med Surg
22:
81-117,
1964[ISI][Medline].
38.
Oyarzun, MJ,
and
Clements JA.
Ventilatory and cholinergic control of pulmonary surfactant in the rabbit.
J Appl Physiol
43:
39-45,
1977
39.
Possmayer, F.
Physicochemical aspects of pulmonary surfactant.
In: Fetal and Neonatal Physiology, edited by Polin RA,
and Fox WW.. Philadelphia, PA: Saunders, 1997, p. 1259-1275.
40.
Prati, M,
Calvo R,
Morreale G,
and
Morreale de Escobar G.
L-Thyroxine and 3,5,3'-triiodothyronine concentrations in the chicken egg and in the embryo before and after the onset of thyroid function.
Endocrinology
130:
2651-2659,
1992[Abstract].
41.
Rubio, S,
Chailley-Heu B,
Ducroc R,
and
Bourbon JR.
Antibody against pulmonary surfactant protein A recognizes proteins in intestine and swim bladder of the freshwater fish, carp.
Biochem Biophys Res Commun
225:
901-906,
1996[ISI][Medline].
42.
Scott, JE,
and
Das RM.
Production of fibroblast-pneumocyte-like factor by fetal rabbit lung fibroblasts: isolation and effects of it and related factors on fetal type II cells in vitro.
Life Sci
53:
765-774,
1993[ISI][Medline].
43.
Scott, JE,
Possmayer F,
Quirie MA,
Tanswell AK,
and
Harding PG.
Alveolar pre-type II cells from the fetal rabbit lung: effect of confluence on the production of disaturated phosphatidylcholine.
Biochim Biophys Acta
879:
292-300,
1986[Medline].
44.
Strayer, DS,
Pinder R,
and
Chander A.
Receptor-mediated regulation of pulmonary surfactant secretion.
Exp Cell Res
226:
90-97,
1996[ISI][Medline].
45.
Sullivan, LC,
Daniels CB,
Phillips ID,
Orgeig S,
and
Whitsett JA.
Conservation of surfactant protein A: evidence for a single origin for vertebrate pulmonary surfactant.
J Mol Evol
46:
131-138,
1998[ISI][Medline].
46.
Torday, JS,
Zinman HM,
and
Nielsen HC.
Glucocorticoid regulation of DNA, protein and surfactant phospholipid in developing lung. Temporal relationship between growth and differentiation.
Dev Pharmacol Ther
9:
125-131,
1986[Medline].
47.
Touchstone, JC,
Chen JC,
and
Beaver KM.
Improved separation of phospholipids in thin layer chromatography.
Lipids
15:
61-62,
1980.
48.
Tyler, WS,
and
Pangborn J.
Laminated membrane surface and osmiophilic inclusions in avian lung epithelium.
J Cell Biol
20:
157-164,
1964
49.
Veldhuizen, RAW,
Nag K,
Orgeig S,
and
Possmayer F.
The role of lipids in pulmonary surfactant.
Biochim Biophys Acta
1408:
90-108,
1998[Medline].
50.
Visschedijk, AHJ
The air space and embryonic respiration. 3. The balance between oxygen and carbon dioxide in the air space of the incubating chicken egg and its role in stimulating pipping.
Br Poult Sci
9:
197-210,
1968[ISI][Medline].
51.
Wetzstein, HY,
Stratton CJ,
and
Olson N.
The stereoscanning electron microscopy and ultrastructural histochemistry of the avian and reptilian surfactant systems: Indian dove, desert spiny and Taiwan golden skink lizards.
Anat Rec
197:
63-73,
1980[Medline].
52.
Wittmann, J,
and
Prechtl J.
Respiratory function of catecholamines during the late period of avian development.
Respir Physiol
83:
375-386,
1991[ISI][Medline].
53.
Wittmann, J,
Steib A,
Liebich HG,
and
Schmidt P.
Accelerating and retarding effects of dexamethasone on the development of the avian lung.
Dev Pharmacol Ther
12:
151-161,
1989.
54.
Wood, PG,
Lopatko OV,
Orgeig S,
Codd JR,
and
Daniels CB.
Control of pulmonary surfactant secretion from type II pneumocytes isolated from the lizard, Pogona vitticeps.
Am J Physiol Regulatory Integrative Comp Physiol
277:
R1705-R1711,
1999
55.
Wood, PG,
Lopatko OV,
Orgeig S,
Joss JM,
Smits AW,
and
Daniels CB.
Control of pulmonary surfactant secretion: an evolutionary perspective.
Am J Physiol Regulatory Integrative Comp Physiol
278:
R611-R619,
2000
56.
Young, SL,
and
Silbajoris R.
Dexamethasone increases adult rat lung surfactant lipids.
J Appl Physiol
60:
1665-1672,
1986
57.
Zeng, X,
Yutzey KE,
and
Whitsett JA.
Thyroid transcription factor-1, hepatocyte nuclear factor-3
and surfactant protein A and B in the developing chick lung.
J Anat
193:
399-408,
1998.
This article has been cited by other articles:
![]() |
E. D. Bruder, P. C. Lee, and H. Raff Dexamethasone treatment in the newborn rat: fatty acid profiling of lung, brain, and serum lipids J Appl Physiol, March 1, 2005; 98(3): 981 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Blacker, S. Orgeig, and C. B. Daniels Hypoxic control of the development of the surfactant system in the chicken: evidence for physiological heterokairy Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R403 - R410. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Torday and V. K. Rehan Deconvoluting Lung Evolution Using Functional/Comparative Genomics Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 8 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Sullivan, S. Orgeig, and C. B. Daniels Control of the development of the pulmonary surfactant system in the saltwater crocodile, Crocodylus porosus Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1164 - R1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ruijtenbeek, J. G. R. De Mey, C. E. Blanco ;, and H. Ehmke The Chicken Embryo in Developmental Physiology of the Cardiovascular System: A Traditional Model with New Possibilities Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R549 - R551. [Full Text] [PDF] |
||||
![]() |
S. D. Johnston, C. B. Daniels, D. Cenzato, J. A. Whitsett, and S. Orgeig The pulmonary surfactant system matures upon pipping in the freshwater turtle Chelydra serpentina J. Exp. Biol., February 1, 2002; 205(3): 415 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Miller, S. Orgeig, C. B. Daniels, and R. V. Baudinette Postnatal development and control of the pulmonary surfactant system in the tammar wallaby Macropus eugenii J. Exp. Biol., January 12, 2001; 204(23): 4031 - 4042. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |